These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1362612)

  • 1. [Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments].
    Ménard J; Chatellier G
    Presse Med; 1992 Nov; 21(37):1762-7. PubMed ID: 1362612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
    JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
    Petrovitch H; Vogt TM; Berge KG
    Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
    Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
    JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
    JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
    Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
    Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
    J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke in the elderly treated for systolic hypertension (SHEP).
    Singer RB
    J Insur Med; 1991; 23(4):265-9. PubMed ID: 10148513
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gallopamil and chlorthalidone versus atenolol and chlorthalidone in the treatment of obstructive hypertrophic cardiomyopathy in patients with arterial hypertension: polycardiographic evaluation of the systolic and diastolic function of the left ventricle].
    Chieppa S; Lobascio C; Brandini V; Iarussi D; Giuliani F; Langella S; De Simone R
    Cardiologia; 1989 Aug; 34(8):695-9. PubMed ID: 2605580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
    Probstfield JL; Applegate WB; Borhani NO; Curb JD; Cutler JA; Davis BR; Furberg CD; Hawkins CM; Lakatos E; Page LB
    Clin Exp Hypertens A; 1989; 11(5-6):973-89. PubMed ID: 2676266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events.
    Furberg CD; Cutler JA
    Hypertension; 1989 May; 13(5 Suppl):I57-61. PubMed ID: 2577460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
    BMJ; 1992 Feb; 304(6824):405-12. PubMed ID: 1445513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future goals for the treatment of hypertension in the elderly with reference to STOP-Hypertension, SHEP, and the MRC trial in older adults.
    Hansson L
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):40S-43S. PubMed ID: 8096706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
    Hypertension; 2003 Sep; 42(3):239-46. PubMed ID: 12925554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.